Sharps Technology, Inc. (STSS)
NASDAQ: STSS · Real-Time Price · USD
3.470
0.00 (0.00%)
Nov 22, 2024, 4:00 PM EST - Market closed
Company Description
Sharps Technology, Inc., a medical device company, engages in the design, research and development, manufacturing, and commercialization of safety syringe products in the United States.
The company provides safety syringe products comprising Securgard, Sologard, and Sharps Provensa that are ultra-low waste syringes for passive, and safety and reuse prevention features, as well as develops prefillable syringe systems.
Sharps Technology, Inc. was incorporated in 2017 and is based in Melville, New York.
Sharps Technology, Inc.
| Country | United States |
| Founded | 2017 |
| IPO Date | Apr 14, 2022 |
| Industry | Medical Instruments & Supplies |
| Sector | Healthcare |
| Employees | 57 |
| CEO | Robert Hayes |
Contact Details
Address: 105 Maxess Road, Suite 124 Melville, New York 11747 United States | |
| Phone | 631-574-4436 |
| Website | sharpstechnology.com |
Stock Details
| Ticker Symbol | STSS |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| IPO Price | $4.25 |
| CIK Code | 0001737995 |
| CUSIP Number | 82003F101 |
| ISIN Number | US82003F1012 |
| Employer ID | 82-3751728 |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| Robert M. Hayes | Chief Executive Officer and Director |
| Ben Scheu | Senior Director of Sales |
| Dr. Steven Hertz M.D. | Chief Medical Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Nov 22, 2024 | S-3/A | [Amend] Registration statement under Securities Act of 1933 |
| Nov 18, 2024 | 1-A/A | Filing |
| Nov 14, 2024 | 10-Q | Quarterly Report |
| Nov 13, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
| Nov 7, 2024 | 8-K | Current Report |
| Nov 6, 2024 | DEF 14A | Other definitive proxy statements |
| Oct 23, 2024 | S-3 | Registration statement under Securities Act of 1933 |
| Oct 15, 2024 | 8-K | Current Report |
| Oct 10, 2024 | 8-K | Current Report |
| Oct 9, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |